Italian pharmacy online: cialis senza ricetta medica in farmacia.
Journal of N eurological P hysical Therapy
From Animal Models to Humans: Strategies for Promoting CNS Axon
Regeneration and Recovery of Limb Function after Spinal Cord Injury
Lawrence Moon,1 Mary Bartlett Bunge1,2
CNS axon tracts and recovery of limb function in animal
There are currently no fully restorative therapies for
human spinal cord injury (SCI). Here, we briefly review the
Although beyond the scope of this review, there are
different types of human SCI pathology as well as the most
other extremely important efforts aimed at restoring nor-
commonly used rodent and nonhuman primate models of
mal function after SCI. For example, following the initial
SCI that are used to simulate these pathologies and to test
insult to the spinal cord, further structure and function is
potential therapies. We then discuss various high profile
lost through active secondary processes.2 Substantial effort
(sometimes controversial) experimental strategies that have
has been devoted to limiting this secondary damage
reported CNS axon regeneration and functional recovery of
through development of neuroprotective measures.3
limb movement using these animal models of SCI. We par-
Substantial effort also has been dedicated to improving
ticularly focus upon strategies that have been tested both in
upon the small degree of endogenous repair that proceeds
rodents and in nonhuman primates, and highlight those
spontaneously in the spinal cord.4,5 For example, strategies
which are currently transitioning to clinical tests or trials in
for improving conduction through spared axons have been
humans. Finally we discuss ways in which animal studies
tested in animals and in humans.6 Strategies for treating
might be improved and what the future may hold for physi-
pain and sexual, bladder, or bowel dysfunction and auto-
cal therapists involved in rehabilitation of humans with SCI.
nomic dysreflexia are also beyond the remit of this article.
plasticity, SCI, regeneration, animal, human, ther-
Readers are directed to excellent recent reviews of these
fields in this volume and elsewhere.1,3,6,7
The present review will first outline different types of
human SCI and will discuss how contemporary animal
Spinal cord injury (SCI) affects hundreds of thousands of
models of SCI attempt to simulate these pathologies. Next,
people worldwide, with massive associated health care and
we will discuss cellular and molecular strategies for improv-
ing CNS axon regeneration and recovery of limb function
results most notoriously in flaccid paralysis and loss of nor-
after SCI. Special consideration will be given to experi-
mal sensation in the limbs below the level of the lesion.
mental strategies that have been evaluated in nonhuman
Spinal cord injury may also lead to debilitating pain, spas-
primates and/or are currently transitioning to clinical stud-
ticity, impairments in breathing and coughing, bowel or
ies or trials.7 We will highlight where strategies remain con-
bladder problems, and reduced reproductive ability or sex-
troversial, and where safety or efficacy barriers to translat-
ual sensation.1 People with SCI may suffer from autonomic
ing experimental strategies exist. The aim is to inform
dysreflexia and may be at increased risk for stroke, decubi-
readers of exciting laboratory advances, but to temper this
tus ulcers, fractures, and depression. There are no fully
with a realistic understanding of the challenges that remain
restorative clinical therapies for SCI.
in developing effective and safe therapies for humans.
In attempts to develop therapeutic strategies for over-
coming each of these sequelae, researchers often rely upon
HUMAN SCI IS PATHOLOGICALLY HETEROGENEOUS
animal models of SCI. These enhance our understanding of
The response of the human spinal cord to injury has
the cellular and molecular response of the mammalian
been studied using imaging techniques as well as by histo-
spinal cord to injury, and they allow us to evaluate the safety
logical staining and inspection of autopsy material.8 These
and efficacy of potential therapies for improving outcome.
studies reveal 4 classes of lesion. In one study of 48 speci-
Use of animal models has shown that dysfunction following
mens,8 in 33% of cases, contusion injuries resulted in cavity
SCI results from interruption of descending and ascending
and cyst formation, typically with some sparing of white
spinal axons and loss of both myelin and cells including
matter (or glial tissue) but with the external glial limiting
neurons, oligodendrocytes, and astrocytes.
membrane (the glia limitans)
remaining intact. In 29% of
regenerate following injury to the peripheral nervous sys-
cases, massive compression or maceration occurred due to
tem (PNS) but few, if any, axons regenerate long distances
vertebral displacement whereas in 21% of cases, laceration
following injury to the central nervous system (CNS).1 This
occurred due to cord penetration by foreign bodies or bony
review will discuss strategies for promoting regeneration of
fragments. After compression, maceration or laceration,
1Post Doctoral Associate,The Miami Project to Cure Paralysis, Miami, FL (firstname.lastname@example.org)2Professor, Departments of Cell Biology and Anatomy and Neurological Surgery, University of Miami Miller School of Medicine,
Journal of N eurological P hysical Therapy
substantial breaks in the glia limitans
led to the epicenter
phases, but here we prefer to specify precise numbers of
being filled predominantly with connective tissue; cysts and
hours, days, months, or years. The majority of animal stud-
cavities were less prominent. In 17% of cases, solid core
ies involve interventions within minutes, hours, or days of
injuries manifested as either central cord syndrome (with
injury. There are far fewer studies reporting improvements
loss of myelin and axons, but with preservation of gray mat-
in CNS axon regeneration or functional outcome after inter-
ter), or as chronic cord compression (with loss of myelin
vening more than one month postinjury23–28 and this imbal-
and/or motor neurons in the epicenter, but with preserva-
ance requires much redressing if CNS axon regeneration is
tion of axonal integrity). The extent of demyelination, the
to be promoted in individuals with long-standing injuries.
invasion of host cells and the deposition of growth-
Additionally, the majority of studies only assess outcomes
inhibitory molecules (see below) at sites of human SCI also
over a period of weeks or months. Relatively few studies
that report improvements in CNS axon regeneration and
Various animal models of SCI have been developed in
functional recovery go on to determine whether these
order to model each of these different types of human
changes remain stable beyond 2 or 3 months.
injury. The relative merits and limitations of these models
Data from animal models show that only a small per-
will be discussed next, since these directly affect the ability
centage of CNS axons need to be spared to mediate rea-
of the researcher to develop safe and effective strategies for
sonable locomotion. Partial locomotion on a treadmill is
improving CNS axon regeneration and motor function after
possible following lesions that spare only 5% to 10% of
axons in adult mammalian thoracic spinal cord.29,30 Forexample, following spinal cord compression in the adult
ANIMAL MODELS OF SCI ARE DESIGNED TO
cat, remaining nerve fibers became myelinated by Schwann
SIMULATE DIFFERENT TYPES OF HUMAN SCI
cells and were able to support spontaneous walking.31
The vast majority of mammalian SCI research is con-
These data are encouraging as they suggest that only a small
ducted using adult mice and rats, although some work has
percentage of axons need to regenerate and form func-
been done using cats and dogs, and increasing work is
tional connections to restore useful function.
being done using nonhuman primates. Contusion injuries
It is important to bear in mind that rodent models only
in the human are typically modeled using devices that dis-
approximate normal human locomotion and dysfunction
place11-12 or impact13 the exposed spinal cord. Compression
after SCI. Bipedal locomotion (humans and birds) differs
injuries may be simulated by subdural insertion and infla-
radically from quadrupedal locomotion (rodents and most
tion of a balloon14 or by clip compression.15 Methods for
mammals) or partially upright locomotion (nonhuman pri-
inducing contusion via vertebral displacement have also
mates) in terms of posture, kinematics, physiology, and
recently been developed.16 Laceration injuries are usually
anatomy. Further, whereas many studies show that rodent
modeled by surgical incision, including complete transec-
spinal cords respond to injury in ways similar to that of the
tion,17,18 dorsal hemisection,19 or lateral hemisection.20 In all
human,32,33 it is clear that there are differences in responses
cases, the aim is to produce reproducible graded (or com-
to SCI between species and even between strains of a given
species.34 For example, whereas many human spinal cord
The animal model selected by the researcher largely
injuries become cystic or cavitated, very little cavitation
depends upon the hypothesis to be tested. Researchers
occurs following contusion injury to many strains of adult
testing neuroprotective strategies often employ contusion
mice.32 The histopathological response of the primate spinal
or compression injuries. Those testing pro-regenerative
cord to injury has been studied only relatively little, includ-
strategies typically prefer models that involve transection of
ing after injection of autologous fibroblasts into otherwise
all tracts (complete) or some tracts (eg, dorsal column for
uninjured rhesus monkeys35 and after contusion injury in
sensory axons ascending in the fasciculi gracilis and cunea-
rhesus monkeys.36–38 This situation is likely to improve since
tus) as these allow one to distinguish regenerating axons
a graded model of contusion injury in marmosets has
from axons that were spared or that sprouted a collateral.21
recently been developed39 and a number of groups are now
Cervical injuries are typically chosen to test therapies for
testing potential therapeutics in nonhuman primates (see
improvement of forelimb movement while thoracic injuries
below). Given the differences between rodent and primate
are usually selected to evaluate therapies for improvement
nervous systems, it seems reasonable to test pro-regenera-
tive therapies in nonhuman primates for safety and efficacy.
In the USA alone, a large number of people live with
The paucity of safety and efficacy studies using nonhuman
existing spinal cord injuries and a substantial number
primates makes it somewhat remarkable therefore that so
receive injuries each year (prevalence ~250,000; incidence
many clinical studies and trials are in progress.7
~11,00022). Different temporal opportunities to intervene
In summary, researchers who test therapeutics designed
therapeutically therefore exist. Thus the time between the
to improve function after SCI select animal models that sim-
injury and the time of treatment and of evaluation in an ani-
ulate particular aspects of the human pathology. Animal
mal model is of critical importance. ‘Acute,’ ‘subchronic,’
models indicate that axon regeneration by a small percent-
and ‘chronic’ have all been used to describe postinjury
age of injured CNS neurons may be sufficient to restore par-
Journal of N eurological P hysical Therapy
tial function. As will be reviewed next, factors intrinsic and
grafts 6 months after implantation abolished electrophysio-
extrinsic to neurons limit CNS axon regeneration.40,41
logical and behavioral recovery, interpreted to mean that
Modulation of these intrinsic and extrinsic factors can pro-
functional improvements were dependent on long tract
mote CNS axon regeneration and recovery of function in
regeneration. In another study, axons from the cortex and
animal models of SCI. As will be described, these successes
brainstem nuclei (including vestibular, red and raphe nuclei,
are leading to clinical tests and trials.
and reticular formation) were also reported as regeneratingbeyond transplants into the distal spinal cord, accompanied
by improvements in hindlimb function including instances
Transplants of peripheral nerve promote CNS axon
regeneration and functional repair after SCI
Using a similar strategy, peripheral nerves have been
Axon regeneration and functional recovery occurs spon-
grafted autologously into nonhuman primates (cynomolo-
taneously (if incompletely) after injury to the adult mam-
gous monkeys) after lateral spinal hemisection20 with evi-
malian PNS. Early experiments therefore attempted to pro-
dence for regeneration of at least some spinal axons at 4
mote CNS axon regeneration by transplantation of PNS seg-
months postinjury. No functional differences were detected
ments into the mammalian CNS. Advances in retrograde trac-
between control and experimental monkeys in this study.
ing techniques allowed the unambiguous demonstration that
This approach also has been used to treat one human
neurons in many (but not all) different regions of the CNS
case of clinically complete SCI, with a report of limited
can regenerate axons into PNS grafts.42 Transplants of periph-
functional recovery.54 This study did not include control
eral nerves as a strategy for promoting CNS axon regenera-
subjects and therefore additional work remains to be done
tion and functional repair are in part attractive because autol-
to determine whether therapies involving peripheral nerve
ogous grafts reduce the risk of immune rejection and obviate
bridge grafting safely and effectively improve outcome after
the consequent need for immunosuppression.
There are limits, however, on the ability of PNS grafts to
promote axon regeneration and functional repair after SCI.
Transplants of Schwann cells promote CNS axon
In rat models of SCI, supraspinal axons (eg, from the red
regeneration and functional repair after SCI
nucleus and from cortex) do not extend axons into periph-
Axon regeneration through peripheral nerves is largely
eral nerve grafts placed into thoracic sites of SCI.43–45 Further,
due to the presence of growth-promoting Schwann cells
CNS axons that do extend into peripheral nerve grafts rarely
(SCs).55 While grafts of peripheral nerve are suited to bridg-
exit grafts distally to form synapses or to restore function
ing regular gaps in the injured human spinal cord, many of
unless routed directly to appropriate targets.46
the cysts and cavities that often form after SCI are irregularly
As a result of these limitations, combination strategies
shaped and below the cord surface, and therefore less
have been tested and found to enhance long distance CNS
amenable to bridging with segments of peripheral nerve.
nerve regeneration and motor recovery following SCI and
Purified SCs have therefore attracted attention as candidates
implantation of peripheral nerve. For example, in adult rats,
for promoting CNS axon regeneration and functional repair
following creation of a gap in the dorsal columns, trans-
after SCI because they can be transplanted as suspensions.
plants of peripheral nerve support regeneration of the cen-
Additionally, use of mitogens allows rat or human (but, to
tral branch of sensory axons from lumbar dorsal root gan-
date, not mouse) SCs from small biopsies of adult peripheral
glia (DRG)47 and some of these axons grow out of grafts
nerve to be dramatically expanded in culture56 to produce
when growth factors are infused rostrally.48,49
sufficient numbers to bridge large gaps in the spinal cord.57
In several studies, multiple segments of intercostal
Purified populations of rat SCs from peripheral nerve
peripheral nerve have been transplanted autologously fol-
have been transplanted into rat models of SCI, injected as
lowing complete thoracic transection and creation of a 5
suspensions 1 week after contusion injury,58 or implanted
mm gap. Nerves were routed from white matter to distal
within channels containing extracellular matrix (Matrigel or
gray matter and secured using fibrin glue containing acidic
fibrin) immediately following lateral hemisection59 or com-
fibroblast growth factor. In studies using adult rats, corti-
plete transection.18 After transection and implantation of
cospinal (CST) axons regenerated through and beyond the
SCs, sensory and spinal axons with cell bodies near the
nerve bridges50 and hindlimb functional recovery was
grafts extend axons into these bridge grafts, are myeli-
reported.51 Importantly, this work recently has been repro-
nated,18 and are electrophysiologically active.60 After contu-
sion and implantation of SCs, less cavitation is observed and
somatosensory and motor cortex-evoked potentials demon-
sensory and spinal axons extend axons into grafts, and are
strated recovery of electrophysiological connectivity from
myelinated.58 In the transection model, regenerating axons
motor cortex to hindlimb muscles and from sciatic nerves
do not leave the grafts distally to reinnervate the host: com-
to sensorimotor cortex.52 Extent of recovery in hindlimb
bination therapies including SCs have therefore been the
function in the open field correlated positively with motor
evoked potential amplitudes in hindlimbs. In some cases,
Various combinations of therapies have been reported
weight supported stepping was reported. Transection of
to enhance long distance CNS nerve regeneration and
Journal of N eurological P hysical Therapy
recovery of hindlimb function following SCI and implanta-
their bodies up a wire grid inclined at 45º and onto a hori-
tion of Schwann cells. Following transection of adult rat
thoracic spinal cord, SCs have been transplanted with deliv-
Primate72 and human OEG73 derived from olfactory bulb
ery of growth factors including brain derived neurotrophic
or lamina propria, are now being tested in rodent and non-
factor (BDNF)61 or BDNF with neurotrophin-3 (NT-3).17 The
human primate models of SCI and demyelination.74 Over
SCs have also been transplanted in combination with anti-
500 transplants of cells from human fetal olfactory bulbs
inflammatory steroids (methylprednisolone),62 and with
have been performed in humans in China with reports of
other regeneration-promoting cells including olfactory
modest rapid improvement in function.75 Because in many
ensheathing glia (OEG).63 Increased regeneration of CNS
cases mild recovery of function is reported to occur within
axons into and beyond bridges was reported in several of
1 or 2 days, it undoubtedly does not depend upon long dis-
these studies. Following thoracic contusion in adult rats,
tance regeneration of CNS axons but perhaps on secretion
SCs compared to OEG were found to be less effective than
of trophic factors or induction of local changes in circuitry.
To date, comprehensive follow-up studies have not been
Purified populations of human SCs from peripheral
performed, so it is difficult to gauge the long-term safety
nerve have also been transplanted into the injured rodent
spinal cord (within channels containing Matrigel).64
avoid rejection of grafted cells, nude rats (that have attenu-
Do transplants of immune/inflammatory cells pro-
ated immune systems and were treated with methylpred-
mote or impair CNS axon regeneration and func-
tional repair after SCI?
regeneration of brainstem-spinal axons into Schwann cell
Spontaneous axon regeneration in the PNS also has been
grafts was observed and propriospinal neurons regenerated
partly attributed to the abundance of inflammatory cells
up to 2.6 mm distal to grafts. Mild functional improvements
including macrophages. Macrophages in the CNS derive
were also reported, including extensive movements of
predominantly from resident microglia but also come from
ankles, knees, and hips (sweeping without weight bearing)
blood-borne monocytes.76 Monocytes enter the CNS more
and occasional weight bearing in stance. Weight-supported
slowly and in fewer number than in the PNS and they differ
stepping was only observed in a single rat.
phenotypically from monocytes that have entered the
To date, SCs have not been transplanted into humans fol-
PNS.77,78 For these reasons, it has been hypothesized that
lowing SCI. A number of hurdles remain. Since transplanting
transplants of monocytes preactivated by exposure to PNS
SCs alone affords only a small level of recovery of function, it
tissue may boost CNS axon regeneration and functional
remains important to find the most effective and repro-
ducible combination therapy involving SCs. It will also be
In one study, homologous monocytes, activated by prein-
important to ensure that transplantation of SCs is safe.
cubation with PNS tissue, were implanted immediately fol-
Although mitogen stimulated human SCs do not form tumors
lowing transection of adult rat thoracic spinal cord, result-
after implantation into mouse PNS, it will be important to
ing in improved CNS axon regeneration.79 Partial recovery
check this after implantation into the injured spinal cord.65
of hindlimb movements was observed during open field
One important step towards human clinical trials would be
locomotor testing. Hindlimb muscle responses were also
to test the safety and efficacy of transplanting autologous SCs
evoked by cortical stimulation. Finally, loss of function after
into nonhuman primates following contusive SCI.39
re-transection was taken to indicate a dependence of recov-ery upon axon regeneration. In a more recent paper, mono-
Transplants of OEG promote CNS axon regeneration
cytes were activated by preincubation with skin, and func-
and functional repair after SCI
tional recovery was reported following implantation into a
Central nervous system axon regeneration and func-
tional recovery also has been reported when OEG are trans-
In stark contrast to these findings, several studies indi-
planted immediately after SCI66–69 or after a delay of 426 or 8
cate that inflammatory cells aggravate outcome after SCI.
weeks.27 In one study using adult rats, following lateral
Subpopulations of macrophages within the injured spinal
hemisection of the cervical spinal cord, injection of OEG
cord are found in regions that subsequently cavitate81 and
improved respiratory function and enhanced performance
intraspinal injection of a macrophage activator (zymosan)
on a climbing task.69 In other studies using adult rats, fol-
worsens cavitation.82 Finally, pharmacological depletion of
lowing thoracic transection and implantation of OEG into
macrophages at 1, 3, and 6 days after injury (using clo-
spinal cord stumps, regeneration of long descending tracts
dronate) actually improves
functional recovery after contu-
important for locomotion has been reported,26,68 even up to
sion injury in adult rats.83 These data argue that transplan-
2.5 cm distally, for serotonergic axons.70 Recovery has also
tation of inflammatory cells risks worsening the original
been reported in adult rats after transection and implanta-
injury and may increase disability after SCI.
tion of OEG when testing hindlimb function using an
Transplantation of inflammatory cells for treatment of
inclined plane.70 Between 3 and 7 months post-transplanta-
SCI is therefore extremely controversial. Replication and
tion, many transplanted rats were capable of propelling
within-experiment comparison of these rodent studies by
Journal of N eurological P hysical Therapy
independent laboratories would be extremely valuable.
Fetal cell grafts slightly reduce neurological dysfunction
Testing of autologous (not allografted), activated monocytes
following human SCI.89 In one study, 41 patients with clini-
would also be informative. To date, we know of no studies
cally complete thoracic spinal cord lesions and progressive
investigating the safety or efficacy of transplanting immune
syringomyelia received multiple subpial grafts of human neo-
or inflammatory cells into injured nonhuman primate
cortex from 8 to 9 week old fetuses usually within 6 to 12
spinal cord. Despite this, clinical trials involving transplan-
months of injury (cited in reference 89). A trend towards
tation of autologous, activated monocytes are currently in
improved neurological outcome over a few dermatomal lev-
progress, supported by Proneuron Biotechnologies.7
els was observed relative to patients who had laminectomy,durotomy, and lysis of adhesions. There were no reports of
Transplants of embryonic/fetal spinal cord promote
morbidity, mortality, or increased pain. However, it should be
CNS axon regeneration and motor recovery after SCI
noted that as yet, there is no available evidence for graft sur-
Fetal spinal cord transplants have been shown to pro-
vival or CNS axon regeneration in humans. Fetal cell grafts
mote regeneration of CNS axons following resection lesions
have also been used in an attempt to prevent additional loss
of adult rat spinal cord and in contused adult rat and cat
of function in cases of progressive syringomyelia and to date
spinal cord. A variety of host axons from distances up to 6
there appear to have been few negative outcomes associated
mm away grow short (<500µm) distances into, and inner-
with transplantation.93,94 Therapeutic strategies involving tis-
vate, the grafts including serotonergic and coerulospinal
sue derived from human embryos or fetuses remain ethically
axons.84 Innervation of the host tissue by transplanted neu-
controversial and therefore clinical trials are additionally
rons is also observed. Despite the attenuation in scar for-
mation induced by transplantation of immature tissue, thenumber of axons to cross the host/graft interfaces in either
Transplants of progenitor cells may improve motor
direction is usually relatively small. Modest but significant
recovery following SCI
functional recovery is observed following transplantation of
Multipotent progenitor cells (cells that have the capacity
immature tissue in rats84 and in cats 1 to 3 months after con-
to differentiate into many
different cell types) and stem
tusion SCI.85 For example, although there was no improve-
cells (cells having the capacity to self-renew indefinitely
ment on inclined plane or grid walking up to 3 months
and differentiate into any
cell type) appear to exist in adults
postimplantation, 2 indices of gait analysis (base of support
as well as in embryos and these may have the potential to
and stride length) showed statistically significant improve-
replace cells of different types that die after SCI. Since it is
ment.86,87 Improvements in locomotion were also observed
in practice difficult (if not impossible) to establish that a
following delayed transplantation of immature tissue into
precursor cell is capable of indefinite division and of differ-
contusion injured adult cat spinal cord and electrophysio-
entiation into all possible phenotypes, here we prefer to use
logical evidence suggested ascending host axons made
the term progenitor. Transplants of purified progenitor cells
synapses with graft neurons.88 However, recovery does not
from embryos and adult tissues are now being tested in ani-
appear to depend on long distance growth into, through
mal models of SCI.95 The following cell types are among
and beyond grafts and the authors of those studies specu-
those that have been transplanted in animal models of SCI:
lated that transplants behave as relays, affording transmis-sion of signals via the transplanted neurons which are
human umbilical cord progenitors,96 bone marrow stromal
innervated by proximal host neurons and project in turn to
cells,97 murine cell-line cells,98 and populations of multipo-
distal host neurons. Grafts may also provide growth factors
tent cells derived from human fetal brain99 and human
or may improve conduction in spared axons, perhaps by
To date, however, where multipotent cells promote
Transplants of embryonic tissue may also enhance func-
recovery of function in animal models of CNS injury, axons
tion of spared circuitry caudal to the lesion thereby improv-
do not appear to regenerate through and beyond grafts.96,98
ing local somatic and visceral responses. One study demon-
One study has shown that immortalized neural progenitors
strated that serotonergic neurons from the embryonic raphe
promote PNS axon growth following SCI.101 Alternative
nucleus grafted caudal to a complete cord transection in the
explanations for recovery of function include cell replace-
adult rat influenced penile erectile function90 and enhanced
ment, creation of new neuronal relays, myelination, neuro-
weight support and treadmill locomotion in spinal rats.91
Since grafts of fetal/embryonic tissue promote recovery
Researchers also have recently begun investigating trans-
but without concomitant long distance axon regeneration
plants of multipotent cells with restricted fates. Grafts of
beyond the graft/host interface, co-treatment strategies
glial-restricted precursors promote mild ingrowth of CST
have been evaluated. In one study, fetal tissue transplanted
Grafted neuronal-restricted precursors extend
2 to 4 weeks after injury, when combined with neu-
axons de novo
after grafting into the intact spinal cord105
rotrophin delivery, promoted regrowth of axons caudal to
although differentiation into mature neurons appears to be
the transection site, resulting in plantar foot placement and
inhibited after grafting into the contusion-injured spinal
weight-supported stepping in adult rats.92
Journal of N eurological P hysical Therapy
Recently, neural progenitors derived from 8 week old
the transplant site.112,114 Forelimb use was also partially
human fetuses have been transplanted into immunosup-
restored, and more so when transplants were placed early
pressed nonhuman primates 9 days following cervical con-
after injury rather than when delayed 6 weeks.28
tusion injury.107 There was a statistically significant differ-
Although many neurons die after axotomy, severely atro-
ence in spontaneous locomotion within the cage and in
phied neurons can be rescued. In one study, severe atrophy
forelimb grip power between marmosets transplanted with
of rubrospinal neurons could be reversed by applying
cells relative to those transplanted with culture medium
BDNF to the cell bodies up to one year after injury.25
only. Eight weeks following transplantation, histopathology
Further, this treatment promoted the regeneration of these
revealed reduced cavitation but no evidence of tumor for-
rubrospinal axons into peripheral nerve transplants
mation. Some surviving grafted cells expressed markers
characteristic of neurons or glia and there was evidence for
Growth factors have also been delivered to the nonhu-
man primate spinal cord using autologous fibroblasts genet-
Autologous transplants of progenitor cells remain to be
tested in rodent or primate models of SCI. Future experi-
implantation into rhesus monkeys, sensory and putative
ments using animals may also show whether it is possible
coerulospinal axons were found to regenerate into NGF-
to induce regeneration and repair by stimulating the
secreting grafts. Since these monkeys had not been given
response of endogenous
adult progenitors. Finally, several
deliberate spinal cord injuries, further work is required to
clinical studies are attempting to evaluate whether trans-
show whether delivery of growth factors promote CNS
plantation of progenitor cells improves outcome after
axon regeneration and functional recovery in injured non-
Disappointingly, clinical trials using systemic delivery of
Delivery of growth factors promotes CNS axon
high doses of neurotrophins for various nervous system dis-
regeneration and motor recovery after SCI
orders have run into a number of difficulties, including
Growth factors potently promote axon regeneration
induction of side effects including severe muscular pain,
during nervous system development and after PNS injury.
fever, depression, and hallucinations.116 Targeted delivery of
Following contusion or transection injury to the adult rat
physiological doses of growth factors (eg, by using viral
spinal cord, however, message levels for many growth fac-
vectors) may prove safer and more efficacious.
tors remain almost undetectable (including neurotrophins3 and 4), or only briefly and slightly upregulated (including
Scar tissue modifiers enhance CNS axon regeneration
nerve growth factor (NGF) and glial cell line-derived neu-
and functional recovery after SCI
Extrinsic factors that limit CNS axon regeneration also
rotrophin receptors on neurons remain absent (trkA), unal-
include factors associated with myelin and the injury site.
tered (trkB, trkC), or only slightly upregulated (p75).108 Brain
Spinal cord injury sites, particularly those resulting from
derived neurotrophic factor may not be available for signal-
penetrating injury, are also typically filled with multiple lay-
ing through its high affinity receptor (trkB) since there is a
ers of fibroblasts. This scar tissue represents a formidable
large, fast, and sustained upregulation of competitor bindingsites (truncated trkB receptors) that may dominate as non-
physical barrier to CNS axon regeneration,117 the cells often
functional sinks for the active neurotrophin.109 In summary,
being oriented perpendicular to the neuraxis (appearing
after SCI, CNS neurons may lack the ability to respond to
geometrically impenetrable) and containing molecular
generally low levels of most growth factors.
inhibitors of growth including chondroitin sulfate gly-
Consequently, to promote CNS axon regeneration and
functional recovery after SCI, supplementary growth fac-
In adult rats, degradation of CS GAGs by delivery of the
tors have been delivered to neuronal cell bodies (eg, in
bacterial enzyme, chondroitinase ABC, promotes regenera-
brainstem or cortex) or SCI sites by direct injection,110 by
tion of injured CNS axons119 and recovery of function after
osmotic minipump,17 by application within fibrin glue,111 or
dorsal hemisection.120 Following spinal cord hemisection in
by gene transfer techniques.61,112-114 Delivery of growth fac-
adult rats, delivery of chondroitinase ABC also promotes
tors can enhance long distance anatomical, electrophysio-
regrowth of axons from spinal cord neurons into grafts of
logical, and behavioral recovery of CNS axons in vivo
peripheral nerve121 and regrowth of CNS axons into spinal
example, following dorsal hemisection lesions of adult rat
cord beyond hemichannel bridges containing SCs and
spinal cord and immediate implantation of NT-3-secreting
Matrigel.122 Following complete transection and implanta-
fibroblasts, CST axons grew up to 8 mm distal to the injury
tion of channels containing SCs and Matrigel, delivery of
site with reduced locomotor deficits on a gridwalk task 1
chondroitinase ABC and immunoglobulin promotes regen-
and 3 months postinjury.113 Following cervical lateral hemi-
eration of serotonergic axons beyond grafts.123 Repeated
section and implantation of BDNF-expressing fibroblasts
intrathecal delivery of chondroitinase ABC also promotes
(together with methylprednisolone and immunosuppres-
hindlimb recovery following severe (but not moderate) tho-
sion), up to 7% of rubrospinal neurons regenerated beyond
Journal of N eurological P hysical Therapy
A number of safety and delivery issues remain to be tack-
those involving transection.111,136 It will also be important to
led. Delivery of bacterial proteins to humans carries a risk
evaluate whether anti-Nogo strategies have any adverse out-
of nonspecific immune responses. Further, repeated dosing
comes in animal models of SCI. One study indicates no
(as is typically performed in animal models of SCI using
increase in tail flick (interpreted as no increase in nocicep-
chondroitinase ABC) may not be possible if the immune sys-
tion) 5 weeks following dorsal overhemisection and deliv-
tem develops responses to neutralize these foreign pro-
ery of IN-1 in adult rats.137 Clinical trials using antibodies
teins. Thus efforts are underway to develop smaller, less
against Nogo-A are currently being planned in association
immunogenic yet enzymatically active variants of chon-
A peptide inhibitor (NEP1-40) targeting a receptor for
matrix metalloproteinases) that cleave CS GAGs might also
Nogo-A (NgR) has also been developed138 in order to pre-
avoid these side effects. Encouragingly, a preparation of
vent neurons from responding to this inhibitor.
chondroitinase ABC is currently being tested in Phase 2 clin-
treatment with NEP1-40 one
ical trials for herniated lumbar discs125 and FDA approval for
week after thoracic dorsal hemisection promotes growth of
this therapy might accelerate clinical trials for SCI. In due
CST axons and serotonergic fibers and a degree of locomo-
course, chondroitinase ABC should be tested for safety and
tor recovery.139 Intrathecal delivery of NEP1-40 also pro-
efficacy in nonhuman primate models of SCI.
motes regrowth of rubrospinal axons and a degree of func-tional recovery after rat SCI.140 Biogen Idec Inc. holds a
Therapies that target myelin inhibitors promote CNS
license for NgR-related therapeutics and clinical trials may
growth and functional recovery
Intact and injured CNS myelin contains a number of dif-
ferent growth inhibitory molecules.126 These include Nogo-
A, myelin-associated glycoprotein (MAG) and oligodendro-
Cyclic adenosine monophosphate
Various strategies exist to boost CNS axon regeneration
have been developed to target and overcome these
by targeting molecules intrinsic to neurons. For example,
inhibitors of axon growth, most notably the antibody IN-1,
levels of cyclic adenosine monophosphate (cAMP) are
which binds to Nogo-A and neutralizes its inhibitory
higher in young, growing neurons than in older neurons.
Levels of cAMP are low in neurons in a state of growth arrest,
The CNS axon growth and recovery of limb function
such as those cultured on growth-inhibitory MAG, and deliv-
have been reported in various animal models of SCI follow-
ery of cAMP analogs relieves this growth-arrest in vitro
ing delivery of anti-Nogo therapeutics.
To test the hypothesis that elevation of cAMP boosts
experiments, small numbers of adult rat CST axons were
CNS axon regeneration in adult rats, cAMP analogs have
observed approximately 1 cm beyond sites of thoracic dor-
been injected into adult rat DRG one week prior to thoracic
sal hemisection following implantation of hybridoma cells
dorsal column hemisection. In 2 studies, centrally project-
secreting IN-1.19,127 Further, between 7 and 12 weeks postle-
ing sensory axons regrew better within injury sites.142,143
sion, low threshold stimulation of hindlimbs enhanced the
Combining strategies, preinjury administration of cAMP
incidence of paw placing responses in 8 of 10 animals
with postinjury delivery of NT-3, promotes regeneration of
treated with IN-1 antibodies but in no control animals, and
sensory axons within and beyond transplants of bone mar-
this effect was abolished by bilateral sensorimotor cortex
row stromal cells.144 In these studies, however, it should be
ablation.128 Administration of IN-1 antibodies also potenti-
noted that administration of cAMP or NT-3 alone did not
ated CST axon growth after dorsal hemisection in adult rats
promote regeneration of axons beyond grafts.
and implantation of embryonic tissue127 or following injec-
Since prophylactic treatments for SCI are inappropriate,
tion of NT-3 either immediately after SCI129 or after a delay
postinjury delivery of drugs that boost cAMP levels are
of 2 or 8 weeks.24 IN-1 also induced CNS axons to sprout
being tested. Postinjury delivery of a cAMP analog pro-
collaterals, for example, following unilateral injury of the
motes CNS axon regeneration after SCI in fish.145
CST at the level of the brainstem.130,131
A fall in the levels of endogenous cAMP after SCI in adult
Recently, and promisingly, IN-1 has been shown to pro-
rats can be prevented by delivery of the phosphodiesterase
mote growth of CST axons following unilateral lesioning in
inhibitor, rolipram, which prevents the hydrolysis of
4 out of 5 marmoset monkeys tested.132 Recombinant,
cAMP.146 After cervical hemisection in adult rats, delivery of
humanized fragments of IN-1 and immunoglobulin G class
rolipram promotes growth of serotonergic axons into fetal
antibodies against Nogo-A have so far been tested in 2 rat
tissue transplants and enhances placing of the impaired
stroke models133 and in a dorsal hemisection model of SCI.134
forelimb during rearing.147 After spinal cord contusion, adult
To date, however, no reports exist of testing anti-Nogo
rats injected intraspinally with SCs and a cyclic AMP analog
therapies in contusion or compression models of SCI. This
together with subcutaneous delivery of rolipram exhibited
is important because anti-Nogo antibodies apparently do
white matter sparing, increased numbers of spinal and
not promote long distance CNS axon regeneration in all
supraspinal axons beyond the injury/transplant site and
models tested,130,131,135 particularly in larger injuries such as
Journal of N eurological P hysical Therapy
Prior to human clinical tests or trials, solo or combina-
ated with mild expression of a limited set of regeneration-
tion methods for elevating cAMP levels after injury need to
associated genes,158 particularly when injury occurs close to
be evaluated for safety and efficacy, at least in rodent mod-
els of SCI and preferably also in nonhuman primates.
transplants of peripheral nerve express various regenera-
Therapeutic windows of delivery of cAMP analogs need to
be defined and doses and methods of delivery established.
In general, however, after injury to the CNS, neurons fail
to re-express the majority of these genes, and do not regen-
Modulation of small enzymes (GTPases) boosts CNS
axon regeneration and recovery of function after
transection, DRG neurons express GAP-43 in their regener-
ating peripheral projections but not in their nonregenerat-
Many different extrinsic factors that impact upon axon
ing central projections following central axotomy in dorsal
regeneration have common final pathways, many signaling
columns.162 It is therefore encouraging that overexpression
intracellularly via small enzymes that interact with guano-
of regeneration-associated genes causes injured CNS neu-
sine triphosphate (GTP; a chemical compound that is used
rons to regenerate axons. For example, simultaneous over-
as a source of energy during synthesis of proteins). This has
expression of GAP43 and CAP23 in transgenic mice causes
been shown for CS GAGs as well as MAG, OMgp, and Nogo-
enhanced neurite growth from explanted DRG in vitro
A.148,149 These GTPases include Rho and Rac family mem-
boosts regeneration of centrally projecting axons from lum-
bers. Injured spinal cords of adult rats contain increased
bar DRG into peripheral nerve grafts implanted in thoracic
levels of message for at least 5 different small GTPases
including RhoA, RhoB, and Rac1.150 Rho and Rac GTPases
Experiments overexpressing regeneration-associated
generally act antagonistically; while Rho family members
genes in CNS neurons in nonhuman primates have not yet
retard growth, Rac family members promote neurite growth
been performed and to our knowledge, therapies specifi-
.151 Consequently, modulators of small GTPases have
cally designed to boost expression of pro-regenerative
been evaluated as methods for promoting CNS axon regen-
genes in neurons after SCI are not yet being considered for
eration and functional recovery in animal models of SCI.
Rho GTPase protein is activated after SCI and inhibition
A number of hurdles remain. In the combination strat-
of Rho (using C3 botulinum toxin) promotes CNS axon
egy described above,163 relatively few neurons regenerated
regeneration and a degree of functional recovery following
and there was no report of testing for recovery of function.
dorsal hemisection injury in adult rats.152 Rho kinase acts as
Future experiments may identify additional, more potent
a downstream effector of Rho, and pharmacologic inhibi-
regeneration-promoting genes. For example, novel regener-
tion of Rho kinase promotes CNS axon regeneration fol-
ation-associated genes have been identified in neurons dur-
lowing dorsal hemisection in adult rats.153
Improved cell-permeable inhibitors of Rho are currently
recently identified a novel set of regeneration-associated
being tested. For example, BioAxone Therapeutic Inc. is
genes that are expressed by injured spinal neurons that
developing technologies to target Rho signaling. Strategies
regenerate into grafts of SCs placed in transected adult rat
to stimulate Rac in vivo
remain to be developed. To date,
spinal cord.165 Future experiments are underway to identify
activators of Rac and inhibitors of Rho and Rho kinase have
genes that potently promote neurite growth in cell culture
neither been tested in rodent models of contusion injury
systems. Targeted upregulation of these growth-promoting
nor in any nonhuman primate models of SCI.
genes (eg, using viral vectors) may prove effective in pro-
Other inhibitors of CNS axon regeneration intrinsic to
moting CNS axon regeneration and functional recovery in
neurons likely exist, and with the advent of molecular
knockdown methods including RNA interference, attemptsto promote CNS axon regeneration through targeting of
Physical therapy enhances recovery of function after
regeneration-inhibiting genes and proteins may become
Although we know of no evidence yet that physical ther-
apy or rehabilitation directly improves CNS axon regenera-
Overexpressing regeneration-promoting molecules
tion after SCI, environmental enrichment, physical therapy,
in neurons promotes CNS axon regeneration
and motor training have been shown to improve limb func-
As axons elongate during development, PNS and CNS
tion in animal models of SCI (including after transection166
neurons express a range of genes154 including growth asso-
and contusion167–169) and in humans with SCI.170–173
ciated protein 43 kDa (GAP-43) and cortical cytoskeleton-
To date, very few studies have combined rehabilita-
associated protein 23 kDa (CAP-23). On maturation, most
tion/physical therapy with strategies for promoting CNS
neurons downregulate expression of these genes. After
axon regeneration and recovery of limb function. In one
injury to the PNS, neurons that re-extend axons re-express
recent study from our laboratory, following transection of
many of these “regeneration-associated” genes.155–157 Injured
adult rat thoracic spinal cord, OEG were transplanted with
CNS neurons do sprout processes locally, and this is associ-
Journal of N eurological P hysical Therapy
through provision of motor enrichment housing (MEH): a
multiple types of progenitor cells. In many cases these
large, multilevel cage filled with ramps, textured surfaces,
claims have been made relative to controls that were not
and hanging food rewards. The return of hindlimb joint
transplanted with cells, but relative to injection of
movement was assessed weekly for 22 weeks starting 1
medium.63,107 Very few studies have directly compared dif-
week postinjury and was compared between animals
ferent cell types within a single experiment,58 so it is very
housed in MEH and those maintained in basic housing (BH).
difficult to know which cell type affords particular benefits
All rats recovered a small amount of hindlimb movement,
over others. In the future, additional control or comparison
but recovery was not accelerated or enhanced by MEH.
groups should be included such as transplants of other cell
Recovered hindlimb movements were, however, sustained
up to 22 weeks postinjury in most rats in MEH, whereas
Worryingly, some pro-regenerative therapies have been
most rats kept in BH progressively lost recovered hindlimb
shown to promote growth of sensory axons within the PNS
movements after 9 weeks. Furthermore, MEH decreased
or CNS. This includes progenitor cells,175 neurotrophin ther-
mortality, and improved health. We conclude that motor
apies,176 anti-inhibitor therapies,110 and regeneration-gene
rehabilitation can be of substantial benefit when using
overexpression therapies.163 In light of this, rigorous testing
transplantation strategies to treat SCI.
for changes in nociception should take place in animal
In the future it seems very likely that rehabilitation/phys-
models of SCI before moving to the human patient. This is
ical therapy will play a key role in many strategies designed
especially important as many humans with SCI rate neuro-
to promote CNS axon regeneration and recovery of limb
logic pain as one of the worst sequelae of SCI.177 Great care
function. These combination strategies will likely first be
should therefore be taken to ensure that any clinical ther-
tested in rodent, then primate models of SCI, and then, if
apy does not induce neurological pain as a side effect.
safe and efficacious, in human clinical trials.
TOWARDS THE FUTURE
Increasing numbers of experimental studies using ani-
In cases of anatomically complete injury in animal mod-
mal models of SCI are resulting in reports of improvements
els, the degree of recovery of hindlimb movement obtained
in CNS axon regeneration and recovery of limb function.
by any single transplant therapy remains functionally slight.
Combinations of these strategies in animal models and in
In general, following transection and intervention of any
humans may lead to additive improvements in outcome
kind in adult rats, plantar placement and weight support on
after SCI. Many of these combination strategies may involve
hindlimbs during stepping is not consistently observed. This
rehabilitation measures and, as clinical tests and trials pro-
includes: (1) transplantation of glia obtained from nasal
ceed, it seems likely that the demand for physical therapists
mucosa or olfactory bulb;26,68 (2) transplantation of activated
with a good working knowledge of pro-repair strategies for
(3) implantation of peripheral nerve grafts
secured across transection gaps with fibrin glue containingacidic fibroblast growth factor;51 and (4) transplantation of
OEG, with or without SC bridges;71 and (5) implantation of
Supported by Christopher Reeve Paralysis Foundation
SC bridges and OEG with delivery of chondroitinase ABC.123
Research Consortium grants, NINDS 09923 and the Miami
To our knowledge there exists only one study that reports
Project to Cure Paralysis (to M.B.B). With thanks to Dr.
frequent plantar placement and weight-supported stepping
Caitlin Hill for suggestions for improving the manuscript
in adult rats with transection injuries.92 This study utilized
and Diana Masella for assistance with manuscript prepara-
delayed transplantation of fetal tissue in combination with
In cases of anatomically incomplete injury, the degree of
recovery witnessed in the open field is typically modest and
Horner PJ, Gage FH. Regenerating the damaged central
most studies remain to be reproduced independently.174
nervous system. Nature.
Replication is extremely desirable in order to determine the
Dusart I, Schwab ME. Secondary cell death and the
general applicability of a therapy. Incomplete injuries are
inflammatory reaction after dorsal hemisection of the rat
notoriously variable and animals should be randomized to
spinal cord. Eur J Neurosci
treatment group, treated blind and evaluated blind. Where
Hall ED, Springer JE. Neuroprotection and acute spinal
possible, baseline testing should be performed prior to
cord injury: a reappraisal. Neurorx
intervention to ensure that groups do not differ one from
Beattie MS, Bresnahan JC, Komon J, et al. Endogenous
another initially. Where axon regeneration is evaluated,
repair after spinal cord contusion injuries in the rat. Exp
stringent criteria should be applied to discriminate this
Bareyre FM, Kerschensteiner M, Rainteau O, Mettenleiter
Many claims have been made as to the particular
TC, Weinmann O, Schwab ME. The injured spinal cord
ative potential of transplants of a given cell type, including
spontaneously forms a new intraspinal circuit in adult
SCs, OEG, monocytes, genetically modified fibroblasts, and
rats. Nat Neurosci
Journal of N eurological P hysical Therapy
Hayes KC. The use of 4-aminopyridine (fampridine) in
Steward O, Zheng B, Tessier-Lavigne M. False resurrec-
demyelinating disorders. CNS Drug Rev
tions: distinguishing regenerated from spared axons in
the injured central nervous system. J Comp Neurol
Amador MJ, Guest JD. A critical appraisal of ongoing
experimental procedures in spinal cord injury. J Neurol
University of Alabama at Birmingham, Dept. of Physical
Medicine & Rehabilitation. Spinal Cord Injury Informa-
Bunge RP, Puckett WR, Hiester ED. Observations on the
tion Network. 1996. Available at: http://www. spinal
pathology of several types of human spinal cord injury,
cord. uab.edu.Accessed April 1, 2005.
with emphasis on the astrocyte response to penetrating
Ye JH, House JD.Treatment of chronically injured spinal
injuries. Adv Neurol.
cord with neurotrophic factors can promote axonalregeneration from supraspinal neurons. Exp. Neurol
Guest JD, Hiester ED, Bunge RP. Demyelination and
Schwann cell response adjacent to injury epicenter cav-
von Meyenburg J, Brosamle C, Metz GA, Schwab ME.
ities following chronic human spinal cord injury. Exp
Regeneration and sprouting of chronically injured corti-
cospinal tract fibers in adult rats promoted by NT-3 and
Bruce JH, Norenberg MD, Krydieh S, Puckett W, Marcillo
the mAb IN-1, which neutralizes myelin-associated neu-
A, Dietrich D. Schwannosis: role of gliosis and proteogly-
rite growth inhibitors. Exp Neurol.
can in human spinal cord injury. J Neurotrauma
Kwon BK, Liu J, Messerer C, et al. Survival and regenera-
tion of rubrospinal neurons 1 year after spinal cord
Jakeman LB, Guan Z, Wei P, et al. Traumatic spinal cord
injury. Proc Natl Acad Sci USA.
injury produced by controlled contusion in mouse. J
Lu J, Feron F, Mackay-Sim A,Waite PM. Olfactory ensheath-
ing cells promote locomotor recovery after delayed
Stokes BT, Noyes DH, Behrmann DL. An electromechan-
transplantation into transected spinal cord. Brain.
ical spinal injury technique with dynamic sensitivity. J
Keyvan-Fouladi N, Raisman G, Li Y. Functional repair of
Gruner JA. A monitored contusion model of spinal cord
the corticospinal tract by delayed transplantation of
injury in the rat. J Neurotrauma
olfactory ensheathing cells in adult rats. J Neurosci.
Martin D, Schoenen J, Delree P, et al. Experimental acute
traumatic injury of the adult rat spinal cord by a subdural
Shumsky JS, Tobias CA, Tumulo M, Long WD, Giszter SF,
inflatable balloon: methodology, behavioral analysis, and
Murray M. Delayed transplantation of fibroblasts geneti-
histopathology. J Neurosci Res
cally modified to secrete BDNF and NT-3 into a spinal
Fehlings MG, Tator CH. The relationships among the
cord injury site is associated with limited recovery of
severity of spinal cord injury, residual neurological func-
function. Exp Neurol.
tion, axon counts, and counts of retrogradely labeled
Eidelberg E, Straehley D, Erspamer R, Watkins CJ.
neurons after experimental spinal cord injury.
Relationship between residual hindlimb-assisted loco-
motion and surviving axons after incomplete spinal cord
Fiford RJ, Bilston LE,Waite P, Lu J.A vertebral dislocation
injuries. Exp Neurol
model of spinal cord injury in rats.
Blight AR. Cellular morphology of chronic spinal cord
injury in the cat: analysis of myelinated axons by line-
Xu XM, Guenard V, Kleitman N,Aebischer P, Bunge MB.A
Blight AR, Young W. Central axons in injured cat spinal
combination of BDNF and NT-3 promotes supraspinal
cord recover electrophysiological function following
axonal regeneration into Schwann cell grafts in adult rat
remyelination by Schwann cells. J Neurol Sci
thoracic spinal cord. Exp Neurol.
Xu XM, Guenard V, Kleitman N, Bunge MB.Axonal regen-
Ma M, Basso DM, Walters P, Stokes BT, Jakeman LB.
eration into Schwann cell-seeded guidance channels
Behavioral and histological outcomes following graded
grafted into transected adult rat spinal cord. J Comp
spinal cord contusion injury in the C57B1/6 mouse. Exp
Schnell L, Schwab ME. Axonal regeneration in the rat
Basso DM, Beattie MS, Bresnahan JC. Graded histological
spinal cord produced by an antibody against myelin-
and locomotor outcomes after spinal cord contusion
associated neurite growth inhibitors. Nature.
using the NYU weight-drop device versus transection.
Levi AD, Dancausse H, Li X, Duncan S, Horkey L, Olivera
Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich
M. Peripheral nerve grafts promoting central nervous
PG. Rats and mice exhibit distinct inflammatory reac-
system regeneration after spinal cord injury in the pri-
tions after spinal cord injury. J Comp Neurol
mate. J Neurosurg Spine
. 2002; 96:197-205.
Journal of N eurological P hysical Therapy
Tuszynski MH, Grill R, Jones LL, McKay HM, Blesch A.
plegic rats: partial restoration of hind limb function.
Spontaneous and augmented growth of axons in the
primate spinal cord: effects of local injury and nerve
Cheng H, Almstron S, Giminez-Llort L, et al. Gait analysis
growth factor-secreting cell grafts. J Comp Neurol
of adult paraplegic rats after spinal cord repair. Exp
Bresnahan JC, King JS, Martin GF, Yashon D. A neu-
Lee YS, Hsiao I, Lin VW. Peripheral nerve grafts and aFGF
roanatomical analysis of spinal cord injury in the rhesus
restore partial hindlimb function in adult paraplegic rats.
monkey (Macaca Mulatta). J Neurol Sci
Lee YS, Lin CY, Robertson RT, Hsiao I, Lin VW. Motor
Bresnahan JC.An electron-microscopic analysis of axonal
recovery and anatomical evidence of axonal regrowth in
alterations following blunt contusion of the spinal cord
spinal cord-repaired adult rats. J Neuropathol Exp
of the rhesus monkey (Macaca mulatta). J Neurol Sci
Cheng H, Liao KK, Liao SF, Chuang TY, Shih YH. Spinal
Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie
cord repair with acidic fibroblast growth factor as a
MS.Apoptosis and delayed degeneration after spinal cord
treatment for a patient with chronic paraplegia. Spine.
injury in rats and monkeys. Nat Med
Iwanami A, Yamane J, Katoh H, et al. Establishment of
Fawcett JW, Keynes RJ. Peripheral nerve regeneration.
graded spinal cord injury model in a nonhuman primate:
Annu Rev Neurosci.
the common marmoset. J Neurosci Res
Morrissey TK, Kleitman N, Bunge RP. Isolation and func-
tional characteristics of Schwann cells derived from
Asher RA, Morgenstern DA, Moon LD, Fawcett JW.
adult peripheral nerve. J Neuroscience.
Chondroitin sulphate proteoglycans: inhibitory compo-
nents of the glial scar. Prog Brain Res.
Xu XM, Chen A, Guenard V, Kleitman N, Bunge MB.
Bridging Schwann cell transplants promote axonal
Caroni P. Neuro-regeneration: plasticity for repair and
regeneration from both the rostral and caudal stumps of
adaptation. Essays Biochem.
transected adult rat spinal cord. J Neurocytol.
Richardson PM, McGuinness UM, Aguayo AJ. Axons from
CNS neurons regenerate into PNS grafts. Nature.
Takami T, Oudega M, Bates ML, Wood PM, Kleitman N,
Bunge MB. Schwann cell but not olfactory ensheathing
Heibert GW, Khodarahmi K, McGraw J, Steeves JD,
glia transplants improve hindlimb locomotor perfor-
Tetzlaff W. Brain-derived neurotrophic factor applied to
mance in the moderately contused adult rat thoracic
the motor cortex promotes sprouting of corticospinal
spinal cord. J Neurosci.
fibers but not regeneration into a peripheral nerve trans-
Bamber NI, Li H, Lu X, Oudega M, Aebischer P, Xu XM.
plant. J Neurosci Res
Neurotrophins BDNF and NT-3 promote axonal re-entry
Richardson PM, McGuinness UM, Aguayo AJ. Peripheral
into the distal host spinal cord through Schwann cell-
nerve autografts to the rat spinal cord: studies with
seeded mini-channels. Eur J Neurosci
axonal tracing methods. Brain Res.
Pinzon A, Calancie B, Oudega M, Noga BR. Conduction of
Tetzlaff W, Kobayashi NR, Giehl KM, Tsui BJ, Cassar SL,
impulses by axons regenerated in a Schwann cell graft in
Bedard AM. Response of rubrospinal and corticospinal
the transected adult rat thoracic spinal cord. J Neurosci
neurons to injury and neurotrophins. Prog Brain Res.
Menei P, Montero-Menei C, Whittemore SR, Bunge RP,
Keirstead SA, Rasminsky M, Fukada Y, Carter DA, Aguayo
Bunge MB. Schwann cells genetically modified to secrete
AJ,Vidal-Sanz M. Electrophysiologic responses in hamster
human BDNF promote enhanced axonal regrowth
superior colliculus evoked by regenerating retinal
across transected adult rat spinal cord. Eur J Neurosci.
Oudega M,Varon S, Hagg T. Regeneration of adult rat sen-
Chen A, Xu XM, Kleitman N, Bunge MB. Methylpredni-
sory axons into intraspinal nerve grafts: promoting
solone administration improves axonal regeneration into
effects of conditioning lesion and graft predegeneration.
Schwann cell grafts in transected adult rat thoracic
spinal cord. Exp. Neurol.
Oudega M, Hagg T. Nerve growth factor promotes regen-
Ramon-Cueto A, Plant GW, Avila J, Bunge MB. Long-dis-
eration of sensory axons into adult rat spinal cord. Exp
tance axonal regeneration in the transected adult rat
spinal cord is promoted by olfactory ensheathing glia
Oudega M, Hagg T. Neurotrophins promote regeneration
transplants. J Neurosci.
of sensory axons in the adult rat spinal cord. Brain Res.
Guest JD, Rao A, Olson L, Bunge MB, Bunge RP.The abil-
ity of human Schwann cell grafts to promote regenera-
Cheng H, Cao Y, Olson L. Spinal cord repair in adult para-
tion in the transected nude rat spinal cord. Exp Neurol
Journal of N eurological P hysical Therapy
Emery E, Li X, Brunschwig JP, Olson L, Levi AD. Assess-
Bomstein Y, Marder JB, Vitner K, et al. Features of skin-
ment of the malignant potential of mitogen stimulated
coincubated macrophages that promote recovery from
human Schwann cells. J Peripher Nerv Syst
spinal cord injury. J Neuroimmunol.
Popovich PG, van Rooijen N, Hickey WF, Preidis G,
Li Y, Field PM, Raisman G. Repair of adult rat corticospinal
McGaughy V. Hematogenous macrophages express CD8
tract by transplants of olfactory ensheathing glia.
and distribute to regions of lesion cavitation after spinal
cord injury. Exp Neurol
Li Y, Field PM, Raisman G. Regeneration of adult rat corti-
Popovich PG, Guan Z, McGaughy V, Fisher L, Hickey WF,
cospinal axons induced by transplanted olfactory
Basso DM.The neuropathological and behavioral conse-
ensheathing cells. J Neurosci
quences of intraspinal microglial/macrophage activa-
Lu J, Feron F, Ho SM, Mackay-Sim A,Waite PM.Transplant-
tion. J Neuropathol Exp Neurol
ation of nasal olfactory tissue promotes partial recovery
Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N,
in paraplegic adult rats. Brain Res.
Stokes BT. Depletion of hematogenous macrophages
Li Y, Decherchi P, Raisman G.Transplantation of olfactory
promotes partial hindlimb recovery and neuroanatomi-
ensheathing cells into spinal cord lesions restores
cal repair after experimental spinal cord injury. Exp
breathing and climbing. J Neurosci
Ramon-Cueto A, Cordero MI, Santos-Benito FF, Avila J.
Bregman BS, Kunkel-Bagden E, Reier PJ, Dai HN, McAtee
Functional recovery of paraplegic rats and motor axon
M, Gao D. Recovery of function after spinal cord injury:
regeneration in their spinal cords by olfactory ensheath-
mechanisms underlying transplant-mediated recovery of
ing glia. Neuron.
function differ after spinal cord injury in newborn and
Moon LDF, Leasure JL, Gage FH, Bunge MB. Motor enrich-
adult rats. Exp Neurol.
ment decreases mortality and maintains recovered
Reier PJ, Anderson DK, Thompson FJ, Stokes BT. Neural
hindlimb movement after thoracic spinal cord injury.
tissue transplantation and CNS trauma: anatomical and
functional repair of the injured spinal cord. J Neuro-
Casas CE, Herrera LP, Corredor R, Margitich I, Kim K,
1992;9 Suppl 1:S223-248.
Stokes BT, Reier PJ. Fetal grafts alter chronic behavioral
olfactory ensheathing glia transplantation following a
outcome after contusion damage to the adult rat spinal
stereotaxic electrolytic lesion of the medullary pyramid.
cord. Exp Neurol.
Soc Neurosci Abstracts
Reier PJ, Stokes BT,Thompson FJ,Anderson DK. Fetal cell
Bianco JI, Perry C, Harkin DG, Mackay-Sim A, Feron F.
grafts into resection and contusion/compression injuries
Neurotrophin 3 promotes purification and proliferation
of the rat and cat spinal cord. Exp Neurol.
of olfactory ensheathing cells from human nose. Glia.
Houle JD, Skinner RD, Garcia-Rill E, Turner KL. Synaptic
Barnett SC, Alexander CL, Iwashita Y, et al. Identification
evoked potentials from regenerating dorsal root axons
of a human olfactory ensheathing cell that can effect
within fetal spinal cord tissue transplants. Exp Neurol.
transplant-mediated remyelination of demyelinated CNS
Reier PJ, Anderson DK, Young W, Michel ME, Fessler R.
Huang H, Chen L,Wang H, et al. Influence of patients’ age
Workshop on intraspinal transplantation and clinical
on functional recovery after transplantation of olfactory
application. J Neurotrauma.
ensheathing cells into injured spinal cord injury. Chin
Privat A, Mansour H, Geffard M. Transplantation of fetal
Med J (Engl).
serotonin neurons into the transected spinal cord of
Popovich PG, Hickey WF. Bone marrow chimeric rats
adult rats: morphological development and functional
reveal the unique distribution of resident and recruited
influence. Prog Brain Res.
macrophages in the contused rat spinal cord. J Neuro-
Ribotta MG, Provencher J, Feraboli-Lohnherr D, Rossignol
pathol Exp Neurol
S, Privat A, Orsal D. Activation of locomotion in adult
Popovich PG, Wei P, Stokes BT. Cellular inflammatory
chronic spinal rats is achieved by transplantation of
response after spinal cord injury in Sprague-Dawley and
embryonic raphe cells reinnervating a precise lumbar
Lewis rats. J Comp Neurol
level. J Neurosci.
George R, Griffin JW. Delayed macrophage responses and
Coumans JV, Lin TT, Dai HN, et al. Axonal regeneration
myelin clearance during Wallerian degeneration in the
and functional recovery after complete spinal cord tran-
central nervous system: the dorsal radiculotomy model.
section in rats by delayed treatment with transplants and
neurotrophins. J Neurosci.
Rapalino O, Lazarov-Spiegler O, Agranov E, et al.
Thompson FJ, Reier PJ, Uthman Mott S, et al. Neuro-phys-
Implantation of stimulated homologous macrophages
iological assessment of the feasibility and safety of neural
results in partial recovery of paraplegic rats. Nat Med.
tissue transplantation in patients with syringo-myelia. J
Journal of N eurological P hysical Therapy
Wildenfalk J, Lundstromer K, Jubran M, Brene S, Olson L.
Wirth ED III, Reier PJ, Fessler RG, et al. Feasibility and
Neurotrophic factors and receptors in the immature and
safety of neural tissue transplantation in patients with
adult spinal cord after mechanical injury or kainic acid.
syringomyelia. J Neurotrauma.
Cao Q, Benton RL, Whittemore SR. Stem cell repair of
Liebl DJ, Huang W,Young W, Parada LF. Regulation of Trk
central nervous system injury. J Neurosci Res.
receptors following contusion of the rat spinal cord. Exp
Saporta S, Kim JJ,Willing AE, Fu ES, Davis CD, Sanberg PR.
Bradbury EJ, Khemani S, King VR, Priestley JV, McMahon
Human umbilical cord blood stem cells infusion in
SB. NT-3 promotes growth of lesioned adult rat sensory
spinal cord injury: engraftment and beneficial influence
axons ascending in the dorsal columns of the spinal
on behavior. J Hematother Stem Cell Res.
cord. Eur J Neurosci
Guest JD, Hesse D, Schnell L, Schwab ME, Bunge MB,
Ankeny DP, McTigue DM, Jakeman LB. Bone marrow
Bunge RP. Influence of IN-1 antibody and acidic FGF-fib-
transplants provide tissue protection and directional
rin glue on the response of injured corticospinal tract
guidance for axons after contusive spinal cord injury in
axons to human Schwann cell grafts. J Neurosci Res.
rats. Exp Neurol.
McDonald JW, Liu XZ, Qu Y, et al.Transplanted embryonic
Liu Y, Himes T, Murray M, Tessler A, Fischer I. Grafts of
stem cells survive, differentiate and promote recovery in
BDNF-producing fibroblasts rescue axotomized rubro-
injured rat spinal cord. Nat Med.
spinal neurons and prevent their atrophy. Exp Neurol.
Stepanov GA, Karpenko DO, Aleksandrova MA, et al.
Xenotransplantation of stem/progenitor cells from
Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH.
human fetal brain to adult rats with spinal trauma. Bull
Cellular delivery of neurotrophin-3 promotes corti-
Exp Biol Med.
cospinal axonal growth and partial functional recovery
Akesson E, Holmberg L, Jonhagen ME, et al A. Solid
after spinal cord injury. J Neurosci
human embryonic spinal cord xenografts in acute and
Liu Y, Kim D, Himes T, et al Transplants of fibroblasts
chronic spinal cord cavities: a morphological and func-
genetically modified to express BDNF promote regener-
tional study. Exp Neurol.
ation of adult rat rubrospinal axons and recovery of fore-
Lu P, Jones LL, Snyder EY,Tuszynski MH. Neural stem cells
limb function. J Neurosci.
constitutively secrete neurotrophic factors and promote
Tuszynski MH, Grill R, Jones LL, McKay HM, Blesch A.
extensive host axonal growth after spinal cord injury.
Spontaneous and augmented growth of axons in the pri-
mate spinal cord: effects of local injury and nerve
Liu S, Qu Y, Stewart TJ, et al. Embryonic stem cells differ-
growth factor-secreting cell grafts. J Comp Neurol
entiate into oligodendrocytes and myelinate in culture
and after spinal cord transplantation. Proc Natl Acad Sci
Apfel SC. Is the therapeutic application of neurotrophic
factors dead? Ann Neurol.
Ogawa Y, Sawamoto K, Miyata T, et al. Transplantation of
in vitro-expanded fetal neural progenitor cells results in
Shearer MC, Fawcett JW. The astrocyte/meningeal cell
neurogenesis and functional recovery after spinal cord
interface-a barrier to successful nerve regeneration? Cell
contusion injury in adult rats. J Neurosci Res.
Silver J, Miller JH. Regeneration beyond the glial scar. Nat
Hill CE, Proschel C, Noble M, et al. Acute transplantation
of glial-restricted precursor cells into spinal cord contu-
Moon LD, Asher RA, Rhodes KE, Fawcett JW.
sion injuries: survival, differentiation, and effects on
Regeneration of CNS axons back to their target follow-
lesion environment and axonal regeneration.
ing treatment of adult rat brain with chondroitinase ABC.
Han SS, Kang DY, Mujtaba T, Rao MS, Fischer I. Grafted
Bradbury EJ, Moon LD, Popat RJ, et al. Chondroitinase
lineage-restricted precursors differentiate exclusively
ABC promotes functional recovery after spinal cord
into neurons in the adult spinal cord. Exp Neurol.
Yick LW,Wu W, So KF,Yip HK, Shum DK. Chondroitinase
Cao QL, Howard RM, Dennison JB, Whittemore SR.
ABC promotes axonal regeneration of Clarke’s neurons
Differentiation of engrafted neuronal-restricted precur-
after spinal cord injury. Neurol Report.
sor cells is inhibited in the traumatically injured spinal
cord. Exp Neurol.
Chau CH, Shum DK, Li H, et al. Chondroitinase ABC
Iwanami A, Kaneto S, Nakamura M, et al. Transplantation
enhances axonal regrowth through Schwann cell-seeded
of human neural stem cells for spinal cord injury in pri-
guidance channels after spinal cord injury. FASEB J.
mates. J Neurosci Res
Journal of N eurological P hysical Therapy
Fouad K, Schnell L, Bunge MB, Schwab ME, Liebscher T,
Merkler D, Metz Ga, Raineteau O, Dietz V, Schwab ME,
Pearse DD. Combining Schwann cell bridges and olfac-
Fouad K. Locomotor recovery in spinal cord-injured rats
tory-ensheathing glia grafts with chondroitinase pro-
treated with an antibody neutralizing the myelin-associ-
motes locomotor recovery after complete transection of
ated neurite growth inhibitor Nogo-A. J Neurosci
the spinal cord. J Neurosci
Caggiano AO, Zimber MP, Ganguly A, Blight AR, Gruskin
GrandPre T, Li S, Strittmatter SM. Nogo-66 receptor antag-
EA. Chondroitinase ABCI improves locomotion and blad-
onist peptide promotes axonal regeneration. Nature.
der function following contusion injury of the rat spinal
cord. J Neurotrauma
Li S, Strittmatter SM. Delayed systemic Nogo-66 receptor
antagonist promotes recovery from spinal cord injury. J
Cao Y, Shumsky JS, Sabol MA, Kushner RA, Tessler A,
Schwab ME. Nogo and axon regeneration. Curr Opin
Strittmatter S. Nogo-66 receptor antagonist peptide
(NEP1-40) promotes functional recovery after spinal
Schnell L, Schwab ME. Sprouting and regeneration of
cord injury. Soc Neurosci Abstracts.
lesioned corticospinal tract fibres in the adult rat spinal
Cai D, Qiu J, Cao Z, McAtee M, Bregman BS, Filbin MT.
cord. Eur J Neurosci.
Neuronal cyclic AMP controls the developmental loss in
Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, Gao D,
ability of axons to regenerate. J Neurosci.
Schwab ME. Recovery from spinal cord injury mediated
by antibodies to neurite growth inhibitors. Nature.
Qiu J, Cai D, Dai H, et al. Spinal axon regeneration induced
by elevation of cyclic AMP. Neuron.
Schnell L, Schneider R, Kolbeck R, Barde YA, Schwab ME.
Neumann S, Bradke F, Tessier-Lavigne M, Basbaum AI.
Neurotrophin-3 enhances sprouting of corticospinal
Regeneration of sensory axons within the injured spinal
tract during development and after adult spinal cord
cord induced by intraganglionic cAMP elevation.
Thallmair M, Metz GA, Z’Graggen WJ, Raineteau O, Kartje
Lu P, Yang H, Jones LL, Filbin MT, Tuszynski MH.
GL, Schwab ME. Neurite growth inhibitors restrict plas-
Combinatorial therapy with neurotrophins and cAMP
ticity and functional recovery following corticospinal
promotes axonal regeneration beyond sites of spinal
tract lesions. Nat Neurosci.
cord injury. J Neurosci.
Z’Graggen WJ, Metz GA, Kartje GL,Thallmair M, Schwab
Bhatt DH, Otto SJ, Depoister B, Fetcho JR. Cyclic AMP-
ME. Functional recovery and enhanced corticofugal plas-
induced repair of zebrafish spinal circuits. Science.
ticity after unilateral pyramidal tract lesion and blockade
of myelin-associated neurite growth inhibitors in adult
Pearse DD, Pereira FC, Marcillo AE, Bates et al. cAMP and
rats. J Neurosci.
Schwann cells promote axonal growth and functional
Fouad K, Klusman I, Schwab ME. Regenerating corti-
recovery after spinal cord injury. Nat Med.
cospinal fibers in the Marmoset (Callitrix jacchus) afterspinal cord lesion and treatment with the anti-Nogo-A
antibody IN-1. Eur J Neurosci.
Nikulina E,Tidwell JL, Dai HN, Bregman BS, Filbin MT.The
Wiessner C, Bareyre FM, Allegrini PR, et al. Anti-Nogo-A
phosphodiesterase inhibitor rolipram delivered after a
antibody infusion 24 hours after experimental stroke
spinal cord lesion promotes axonal regeneration and
improved behavioral outcome and corticospinal plastic-
functional recovery. Proc Natl Acad Sci USA.
ity in normotensive and spontaneously hypertensive
rats. Cereb Blood Flow Metab.
Jain A, Brady-Kalnay SM, Bellamkonda RV. Modulation of
Schnell L, Liebscher T,Weinmann O, Schneider R, Scholl J,
Rho GTPase activity alleviates chondroitin sulfate pro-
teoglycan-dependent inhibition of neurite extension. J
recovery in rats treated with antibodies to Nogo-A and in
Nogo-A knockout mice. Soc Neurosci Abstracts.
Schweigreiter R,Walmsley AR, Niederost B, et al.Versican
V2 and the central inhibitory domain of Nogo-A inhibit
Chierzi S, Strettoi E, Cenni MC, Maffei L. Optic nerve
neurite growth via p75NTR/NgR-independent pathways
crush: axonal responses in wild-type and bcl-2 transgenic
that converge at RhoA. Mol Cell Neurosci.
mice. J Neurosci.
Oudega M, Rosano C, Sadi D,Wood PM, Schwab ME, Hagg
Erschbamer MK, Hofstetter CP, Olson L. RhoA, RhoB,
T. Neutralizing antibodies against neurite growth
RhoC, Rac1, Cdc42, and Tc10 mRNA levels in spinal cord,
inhibitor NI-35/250 do not promote regeneration of sen-
sensory ganglia, and corticospinal tract neurons and
sory axons in the adult rat spinal cord. Neuroscience.
long-lasting specific changes following spinal cord
injury. J Comp Neurol.
Journal of N eurological P hysical Therapy
Niederost B, Oertle T, Fritsche J, McKinney RA, Bandtlow
Costigan M, Befort K, Karchewski L, et al. Replicate high-
CE. Nogo-A and myelin-associated glycoprotein mediate
density rat genome oligonucleotide microarrays reveal
neurite growth inhibition by antagonistic regulation of
hundreds of regulated genes in the dorsal root ganglion
RhoA and Rac1. J Neurosci.
after peripheral nerve injury. BMC Neurosci
Dubreuil CI, Winton MJ, McKerracher L. Rho activation
Moon LDF, Torres-Munoz JE, Petito CK, et al. Identifica-
patterns after spinal cord injury and the role of activated
tion of genes expressed by laser captured spinal cord
Rho in apoptosis in the central nervous system. J Cell
neurons regenerating an axon into a Schwann cell bridge
transplanted after thoracic transection. In press. Society
Fournier AE, Takizawa BT, Strittmatter SM. Rho kinase
inhibition enhances axonal regeneration in the injured
De Leon RD, Hodgson JA, Roy RR, Edgerton VR.
CNS. J Neurosci.
Locomotor capacity attributable to step training versus
Bulsara KR, Iskandar BJ,Villavicencio AT, Skene JH.A new
spontaneous recovery after spinalization in adult cats. J
millenium for spinal cord regeneration: growth-associ-
ated genes. Spine.
Lankhorst AJ, ter Laak MP, van Laar TJ, et al. Effects of
Tetzlaff W, Alexander SW, Miller FD, Bisby MA. Response
enriched housing on functional recovery after spinal
of facial and rubrospinal neurons to axotomy: changes in
cord contusive injury in the adult rat. J Neurotrauma
mRNA expression for cytoskeletal proteins and GAP-43.
Van Meeteren NL, Eggers R, Lankhorst AJ, Gispen WH,
Woolf CJ, Reynolds ML, Molander C, O’Brien C, Lindsay
Hamers FP. Locomotor recovery after spinal cord contu-
RM, Benowitz LI.The growth-associated protein GAP-43
sion injury in rats is improved by spontaneous exercise.
appears in dorsal root ganglion cells and in the dorsal
horn of the rat spinal cord following peripheral nerve
Hutchinson KJ, Gomez-Pinilla F, Crowe MJ,Ying Z, Basso
DM.Three exercise paradigms differentially improve sen-
Tetzlaff W, Zwiers H, Lederis K, Cassar L, Bisby MA.
sory recovery after spinal cord contusion in rats. Brain.
Axonal transport and localization of B-50/GAP-43-like
immunoreactivity in regenerating sciatic and facial
Wernig A, Muller S. Laufband locomotion with body
nerves of the rat. J Neurosci.
weight support improved walking in persons with
Mason MR, Lieberman AR, Grenningloh G,Anderson PN.
severe spinal cord injuries. Paraplegia.
Transcriptional upregulation of SCG10 and CAP-23 is
correlated with regeneration of the axons of peripheral
human spinal cord injury: a series of case studies. Phys
and central neurons in vivo. Mol Cell Neurosci.
Field-Fote EC, Tepavac D. Improved intralimb coordina-
Chaisuksunt V, Campbell G, Zhang Y, Schachner M,
tion in people with incomplete spinal cord injury fol-
Lieberman AR,Anderson PN. Expression of regeneration-
lowing training with body weight support and electrical
related molecules in injured and regenerating striatal
stimulation. Phys Ther
and nigral neurons. J Neurocytol.
McDonald JW, Becker D, Sadowsky CL, Jane JA Sr,
Chaisuksunt V, Zhang Y,Anderson PN, et al.Axonal regen-
Conturo TE, Schultz LM. Late recovery following spinal
eration from CNS neurons in the cerebellum and brain-
cord injury. Case report and review of the literature. J.
stem of adult rats: correlation with the patterns of
expression and distribution of messenger RNAs for L1,
Kleitman N. Keeping promises: translating basic research
CHL1, c-jun and growth-associated protein-43. Neurosci-
into new spinal cord injury therapies. J Spinal Cord
Campbell G, Hutchins K,Winterbottom J, Grenningloh G,
Hofstetter CP, Holmstrom NA, Lilja JA, et al. Allodynia lim-
Lieberman AR, Anderson PN. Upregulation of activating
its the usefulness of intraspinal neural stem cell grafts;
transcription factor 3 (ATF3) by intrinsic CNS neurons
directed differentiation improves outcome.
regenerating axons into peripheral nerve grafts. Exp
Romero MI, Rangappa N, Li L, Lightfoot E, Garry MG,
Chong MS, Woolf CJ, Turmaine M, Emson PC, Anderson
Smith GM. Extensive sprouting of sensory afferents and
PN. Intrinsic versus extrinsic factors in determining the
hyperalgesia induced by conditional expression of nerve
regeneration of the central processes of rat dorsal root
growth factor in the adult spinal cord. J Neurosci.
ganglion neurons: the influence of a peripheral nerve
graft. J Comp Neurol.
Widerstrom-Noga EG,Turk DC.Types and effectiveness
Bomze HM, Bulsara KR, Iskandar BJ, Caroni P, Skene JH.
of treatments used by people with chronic pain associ-
Spinal axon regeneration evoked by replacing two
ated with spinal cord injuries: influence of pain and
growth cone proteins in adult neurons. Nat Neurosci.
psychosocial characteristics. Spinal Cord.
Review of Operations Brokerage Outline of the Business The Brokerage Segment primarily offers support services seller, or sometimes both), up to a maximum of “propertyto clients in buying and selling real estate, with a focus onprice x 3% + ¥60,000,” in accordance with Ministry ofexisting condominiums and single-family houses. We pro-La
“The Quantitative analysis of Uranium Isotopes in the population of PortHope, Ontario Canada” authored by Durakovic, Gerdes, and Zimmerman Prepared for the Municipality of Port HopeProgram in Occupational Health and Environmental MedicineThe Departments of Family Medicine and Public Health Sciences Executive Summary This review of the document entitled “The Quantitative analysis of Ur